Company intelligence / Profile preview
Shenzhen Misheng Biotechnology
- Ownership
- Private
- Development stage
- Other
Overview
Shenzhen Misheng Biotechnology is a clinical-stage Chinese biotechnology company specializing in the development of advanced cell therapies for oncology. The company's core focus is on T-cell receptor-engineered T-cell (TCR-T) therapies, utilizing its proprietary Hi-TCR-T platform to target solid tumors. Its lead clinical candidate is a multi-targeted TCR-T therapy directed against prostate-specific membrane antigen (PSMA), NKG2D ligands (NKG2DL), and fibroblast activation protein (FAP). This candidate is currently in Phase 1 clinical development for the treatment of prostatic neoplasms and other solid tumors.
- Therapeutic areas
- Oncology
- Modalities
- T cell receptor engineered T cell therapyCell therapyBiologic
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Shenzhen Misheng Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhen Misheng Biotechnology.